Annual ROE
-54.83%
+14.88%+21.35%
December 31, 2024
Summary
- As of March 2, 2025, TARS annual return on equity is -54.83%, with the most recent change of +14.88% (+21.35%) on December 31, 2024.
- During the last 3 years, TARS annual ROE has fallen by -46.52% (-559.81%).
- TARS annual ROE is now -156.28% below its all-time high of 97.42%, reached on December 31, 2018.
Performance
TARS ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-48.70%
+8.44%+14.77%
December 31, 2024
Summary
- As of March 2, 2025, TARS quarterly return on equity is -48.70%, with the most recent change of +8.44% (+14.77%) on December 31, 2024.
- Over the past year, TARS quarterly ROE has increased by +8.44% (+14.77%).
- TARS quarterly ROE is now -172.21% below its all-time high of 67.44%, reached on March 31, 2020.
Performance
TARS Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TARS ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.4% | +14.8% |
| 3 y3 years | -559.8% | -525.2% |
| 5 y5 years | -170.5% | -239.7% |
TARS ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -559.8% | +21.4% | -525.2% | +33.8% |
| 5 y | 5-year | -170.5% | +21.4% | -172.2% | +72.4% |
| alltime | all time | -156.3% | +21.4% | -172.2% | +72.4% |
Tarsus Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -54.83%(-21.3%) | -48.70%(-14.8%) |
| Sep 2024 | - | -57.14%(-17.3%) |
| Jun 2024 | - | -69.10%(-6.1%) |
| Mar 2024 | - | -73.59%(+0.1%) |
| Dec 2023 | -69.71%(+101.9%) | -73.48%(+27.1%) |
| Sep 2023 | - | -57.82%(+19.3%) |
| Jun 2023 | - | -48.47%(+39.6%) |
| Mar 2023 | - | -34.73%(+4.4%) |
| Dec 2022 | -34.53% | -33.28%(-3.4%) |
| Sep 2022 | - | -34.46%(+10.8%) |
| Jun 2022 | - | -31.09%(+21.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -25.52%(+227.6%) |
| Dec 2021 | -8.31%(-48.5%) | -7.79%(+34.3%) |
| Sep 2021 | - | -5.80%(+55.5%) |
| Jun 2021 | - | -3.73%(-75.3%) |
| Mar 2021 | - | -15.09%(-62.4%) |
| Dec 2020 | -16.15%(-120.8%) | -40.11%(-77.2%) |
| Sep 2020 | - | -176.19%(+459.5%) |
| Jun 2020 | - | -31.49%(-146.7%) |
| Mar 2020 | - | 67.44%(+93.5%) |
| Dec 2019 | 77.77%(-20.2%) | 34.85% |
| Dec 2018 | 97.42% | - |
FAQ
- What is Tarsus Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual ROE year-on-year change?
- What is Tarsus Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly ROE year-on-year change?
What is Tarsus Pharmaceuticals annual return on equity?
The current annual ROE of TARS is -54.83%
What is the all time high annual ROE for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual return on equity is 97.42%
What is Tarsus Pharmaceuticals annual ROE year-on-year change?
Over the past year, TARS annual return on equity has changed by +14.88% (+21.35%)
What is Tarsus Pharmaceuticals quarterly return on equity?
The current quarterly ROE of TARS is -48.70%
What is the all time high quarterly ROE for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly return on equity is 67.44%
What is Tarsus Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, TARS quarterly return on equity has changed by +8.44% (+14.77%)